BionTech raises $ 250 million from investors – Temasek gets on

Frankfurt (Reuters) – Mainz biotech company BionTech has secured around $ 250 million in fresh capital from investors.

Donors include Singapore’s Temasek sovereign wealth fund, as BionTech announced on Monday. …